Wilmington, Delaware, Nov. 03, 2023 (GLOBE NEWSWIRE) -- According to RationalStat’s most recent industry analysis, the Global Monoclonal Antibodies Market value is US$ 196.6 billion in 2023 and is expected to rise at a strong CAGR of over 9.2% over the forecast period of 2023-2030.
Market Definition, Market Scope, and Report Overview
Monoclonal antibodies (mAbs) are laboratory-created molecules that mimic the immune system's ability to combat infections such as viruses or cancer cells. These antibodies are designed to target certain proteins on the surface of cells, assisting the immune system in more effectively identifying and neutralizing dangerous cells.
Monoclonal antibodies are widely employed in cancer treatment. They can directly target cancer cells, disrupt signals that promote tumor growth, activate the immune system to attack cancer cells or deliver toxins to cancer cells. The ongoing discovery of new cancer targets and the development of related monoclonal antibodies help to drive market growth.
- According to a deep-dive market assessment by RationalStat, the global Monoclonal Antibodies market has been analyzed on the basis of market segments, including source type, production type, application, end use and geography/regions (including North America, Latin America, Western Europe, Eastern Europe, Middle East & Africa, and Asia Pacific). The report also offers global and regional market sizing for the historical period of 2019-2022 and the forecast period of 2023-2030.
- Market intelligence for the global Monoclonal Antibodies market covers market sizes on the basis of market value (US$/EUR Million) and volume (Units) by various products/services/equipment, demand assessment across the key regions, customer sentiments, price points, cost structures, margin analysis across the value chain, financial assessments, historical and forecast data, key developments across the industry, import-export data, trade overview, components market by leading companies, etc.
- In addition, the long-term sector and products/services 10-year outlook and its implications on the global Monoclonal Antibodies market. It also includes the industry's current state – Production Levels, Capacity Utilization, Tech quotient, etc. Key information will be manufacturing capacity by country, installed base, import volumes, market size, key players, market size, dynamics, market data, insights, etc.
Request A Customization- https://store.rationalstat.com/store/global-monoclonal-antibodies-market/#tab-ux_global_tab
Global Monoclonal Antibodies Market: Segmental and Market Share Analysis
- On the basis of source type, in 2022, the human source type segment retained the highest share, accounting for 52% of the overall market share. Human monoclonal antibodies modulate effector functions efficiently and are less immunogenic than chimeric or humanized monoclonal antibodies.
- On the basis of production type, In vitro segment dominated the market with 73% in 2022 because of its economic viability in lengthy production runs and decreased proclivity for contamination with foreign antigens,
Report Synopsis
| Report Metrics | Details |
| Base Year | 2023 |
| Forecast Period | 2023-2030 |
| Base Year Market Size | US$ 196.6 billion |
| Market Size Forecast | US$ 364 billion |
| Growth Rate | 9.2% |
| Dominant Segment | In vitro |
| Dominant Region | North America |
| Key Market Drivers |
|
| Companies Profiled |
|
Explore more about this report- https://store.rationalstat.com/store/global-monoclonal-antibodies-market/#tab-ux_global_tab
Competition Analysis and Market Structure
Some leading players adopt various strategies to reinforce their market share and gain a competitive edge over other competitors in the market. Mergers & acquisitions, partnerships and collaborations, and product launches are some of the strategies followed by industry players. Some of the key developments in the global monoclonal antibodies market include,
- In March 2022, Sanofi S.A. and Blackstone Life Sciences signed a partnership to accelerate the development of a subcutaneous version of Sarclisa mAb for the treatment of multiple myeloma patients.
Some of the prominent players and suppliers operating and contributing significantly to the global monoclonal antibodies market growth include F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Pfizer Inc., Novartis International AG, Merck & Co., Inc., AbbVie Inc., Bristol-Myers Squibb Company, Amgen Inc., Eli Lilly and Company, AstraZeneca plc, Regeneron Pharmaceuticals, Inc., Sanofi S.A., GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, and Takeda Pharmaceutical Company Limited, among others.
Get A Free Sample- https://store.rationalstat.com/store/global-monoclonal-antibodies-market/#tab-ux_global_tab
RationalStat has segmented the global monoclonal antibodies market based on source type, production type, application, end use, and region
- Global Monoclonal Antibodies Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Source Type
- Murine
- Chimeric
- Humanized
- Human
- Global Monoclonal Antibodies Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Production Type
- In Vivo
- In Vitro
- Global Monoclonal Antibodies Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Application
- Oncology
- Autoimmune Diseases
- Infectious Diseases
- Neurological Diseases
- Global Monoclonal Antibodies Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by End Use
- Hospitals
- Specialty Centers
- Others
- Global Monoclonal Antibodies Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Region
- North America Monoclonal Antibodies Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Country
- US
- Canada
- Latin America Monoclonal Antibodies Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Country
- Brazil
- Mexico
- Rest of Latin America
- Western Europe Monoclonal Antibodies Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Country
- Germany
- UK
- France
- Spain
- Italy
- Benelux
- Nordic
- Rest of Western Europe
- Eastern Europe Monoclonal Antibodies Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Country
- Russia
- Poland
- Hungary
- Other CIS Countries
- Rest of Eastern Europe
- Asia Pacific Monoclonal Antibodies Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Country
- China
- Japan
- India
- South Korea
- Australia
- ASEAN
- Indonesia
- Thailand
- Philippines
- Vietnam
- Malaysia
- Rest of ASEAN
- Rest of Asia Pacific
- Middle East & Africa Monoclonal Antibodies Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Country
- GCC
- Saudi Arabia (KSA)
- United Arab Emirates (UAE)
- Rest of the GCC
- South Africa
- Nigeria
- Turkey
- Rest of the Middle East & Africa
- GCC
- North America Monoclonal Antibodies Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Country
For more information about this report- https://store.rationalstat.com/store/global-monoclonal-antibodies-market/#tab-ux_global_tab
Key Questions Answered in the Monoclonal Antibodies Report:
- What will be the market value of the global Monoclonal Antibodies market by 2030?
- What is the market size of the global Monoclonal Antibodies market?
- What are the market drivers of the global Monoclonal Antibodies market?
- What are the key trends in the global Monoclonal Antibodies market?
- Which is the leading region in the global Monoclonal Antibodies market?
- What are the major companies operating in the global Monoclonal Antibodies market?
- What are the market shares by key segments in the global Monoclonal Antibodies market?
Running a year End discount of 20%-https://store.rationalstat.com/store/global-monoclonal-antibodies-market/#tab-ux_global_tab
Explore Our Trending Reports
- Global Hormone Replacement Therapy Market- The Global Hormone Replacement Therapy Market is expected to grow at a CAGR of 5.1% over the forecast period of 2022-2028.
- Global Animal Model Market Analysis and Trends- The Global Animal Model Market is expected to grow at a CAGR of 6.1% over the forecast period of 2022-2028.
- Global Hard Gelatin Capsules Market Analysis and Forecast- The pharmaceutical industry is witnessing significant growth globally, driven by factors such as rising healthcare expenditure, increasing prevalence of chronic diseases, and advancements in drug development.
- Global Analgesics Market - The Global Analgesics Market is expected to grow at a CAGR of 6.6% over the forecast period of 2022-2028.
- Global Over-the-Counter (OTC) Drugs Market- The global Over the Counter Drugs Market is expected to grow at a CAGR of 6.6% over the forecast period of 2022-2028.
- Global Mental Health Software Market- The global mental health software market was US$ 4.5 Bn in 2021 and is expected to grow at a significant pace of 11.5% over the forecast period.
- Global advanced wound care market- The global advanced wound care market was valued at US$ 9.87 billion in 2022 and is expected to grow at a CAGR of 6.2% from 2023 to 2028.
- Global Dental Implant Market- The global dental implant market is projected to expand at a CAGR of 9% during the forecast period. Increasing applications of dental implants in various therapeutic areas, as well as rising demand for prosthetics, are among the key factors anticipated to drive dental implant market expansion.
- Global Anti-Aging Market- The global Anti-Aging market was US$ 55.0 Bn in 2022 and is estimated to reach over US$ 88.0 Bn by 2028, growing at a CAGR of 6.9% over the forecast period of 2023-2028.
- Global Cartilage Repair and Cartilage Regeneration Market- The global Cartilage Repair and Cartilage Regeneration Market is expected to grow at a CAGR of 8% over the forecast period of 2022-2028.
Research Methodology
RationalStat has developed a state-of-the-art research methodology to crunch numbers and provide the best possible real-time insights to clients. We combine a varied range of industry experience, data analytics, and experts’ viewpoint to create a research methodology for market sizing and forecasting.
RationalStat combines a mix of secondary sources as well as primary research to assess the market size and develop a forecast. Key steps involved in accurately deriving the market numbers are:
- Defining the problem by understanding the type of market and data required by the client.
- Data gathering and collection through relevant paid databases, publicly available sources, company reports, annual reports, surveys, and interviews.
- Formulating a hypothesis to create market numbers, forecasts, influencing factors, and their relevance.
- Evaluating and analyzing the data by referring to data sources utilized and leveraged.
- Validating, interpreting, and finalizing the data by combining the details gathered from primary and secondary sources with the help of experienced analysts.
Download Key Insights and Market Data - Raise a Query
About RationalStat LLC
RationalStat is an end-to-end global market intelligence and consulting company that provides comprehensive market research reports, customized strategy, and consulting studies. The company has sales offices in India, Mexico, and the US to support global and diversified businesses. The company has over 80 consultants and industry experts, developing more than 850 market research and industry reports for its report store annually.
RationalStat has strategic partnerships with leading data analytics and consumer research companies to cater to the client’s needs. Additional services offered by the company include consumer research, country reports, risk reports, valuations and advisory, financial research, due diligence, procurement and supply chain research, data analytics, and analytical dashboards.
Contact
RationalStat LLC
Kimberly Shaw,
Content and Press Manager
US Phone: +1 302 803 5429
UK Phone: +44 203-287-1245
LinkedIn | Facebook | Twitter | Instagram | Pinterest
